Dependence of radioactive iodine-131 capture by the lacrimal ducts on the tear production level

被引:3
|
作者
Yartsev, Vasily D. [1 ]
Sheremeta, Marina S. [2 ]
Trukhin, Alexey A. [2 ,3 ]
Atkova, Eugenia L. [1 ]
Degtyarev, Mikhail V. [4 ]
Yasyuchenya, Valentina S. [2 ]
Yudakov, Danila V. [5 ,6 ]
机构
[1] MM Krasnov Res Inst Eye Dis, Lacrimal Pathol Dept, Moscow, Russia
[2] Endocrinol Res Ctr, Radionuclide Therapy Dept, Moscow, Russia
[3] Natl Res Nucl Univ MEPhI, Deaprtment Comp Med Syst 46, Moscow Engn Phys Inst, Moscow, Russia
[4] Endocrinol Res Ctr, Radionuclide Diagnost Dept, Moscow, Russia
[5] Endocrinol Res Ctr, Radiat Safety Dept, Moscow, Russia
[6] Natl Res Nucl Univ MEPhI, Dept Med Phys 35, Moscow Engn Phys Inst, Moscow, Russia
关键词
Nasolacrimal duct/etiology; nasolacrimal duct/growth and development; nasolacrimal duct/pathology; nasolacrimal duct/physiology; thyroid neoplasms/complications; RADIOIODINE THERAPY; DRAINAGE SYSTEM; THYROID-CANCER; OBSTRUCTION; EPIPHORA;
D O I
10.4103/IJO.IJO_2780_22
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: Secondary acquired lacrimal duct obstruction (SALDO) is one of the complications of radioiodine therapy. SALDO is formed a few months after therapy if there is a sufficient uptake of radioactive iodine by the nasolacrimal duct. To date, risk factors leading to SALDO are unclear. The objective was to determine the correlation between the tear production level and radioactive iodine-131 uptake in the lacrimal ducts. Methods: Basal and reflex tear production was studied in 64 eyes prior to the therapy with radioactive iodine-131 after drug-induced hypothyroidism. The condition of the ocular surface was assessed using the Ocular Surface Disease Index (OSDI) questionnaire. Seventy-two hours after the radioactive iodine therapy, scintigraphy was performed, which determined the presence or absence of iodine-131 in the lacrimal ducts. T-statistics and the Mann-Whitney criterion were used to identify the differences between the groups. The differences were considered significant at P <= 0.05. The current tear production level in patients receiving radioiodine therapy was determined using a mathematical model. Results: A statistically significant difference between the basal (p = 0.044) and reflex (p = 0.015) tear production levels was found in cases with and without iodine-131 uptake by the lacrimal ducts. The probable current tear production level corresponds to the sum of basal and 10-20% of reflex tear production. The uptake of iodine-131 was found regardless of the OSDI results. Conclusion: The probability of iodine-131 uptake by the lacrimal ducts rises as the tear production level increases.
引用
收藏
页码:1828 / 1832
页数:5
相关论文
共 50 条
  • [41] Preparation and Characterization of Hyaluronic Acid-Polycaprolactone Copolymer Micelles for the Drug Delivery of Radioactive Iodine-131 Labeled Lipiodol
    Chen, Shih-Cheng
    Yang, Ming-Hui
    Chung, Tze-Wen
    Jhuang, Ting-Syuan
    Yang, Jean-Dean
    Chen, Ko-Chin
    Chen, Wan-Jou
    Huang, Ying-Fong
    Jong, Shiang-Bin
    Tsai, Wan-Chi
    Lin, Po-Chiao
    Tyan, Yu-Chang
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [42] The likely transformation of papillary thyroid carcinoma into anaplastic carcinoma during postoperative radioactive iodine-131 therapy: Report of a case
    Shingu, K
    Kobayashi, S
    Yokoyama, S
    Fujimori, M
    Asanuma, K
    Ito, K
    Hama, Y
    Maruyama, M
    Kusama, R
    Amano, J
    SURGERY TODAY, 2000, 30 (10) : 910 - 913
  • [43] Recurrence-free survival and prognosis after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma
    Iizuka, Yusuke
    Katagiri, Tomohiro
    Ogura, Kengo
    Inoue, Minoru
    Nakashima, Ryota
    Nakamura, Kiyonao
    Mizowaki, Takashi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [44] Recurrence-free survival and prognosis after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma
    Yusuke Iizuka
    Tomohiro Katagiri
    Kengo Ogura
    Minoru Inoue
    Ryota Nakashima
    Kiyonao Nakamura
    Takashi Mizowaki
    Scientific Reports, 13
  • [45] Stunning phenomenon after a radioactive iodine-131 diagnostic whole-body scan: Is it really a point of clinical consideration?
    Amin, Amr
    Amin, Mahasen
    Badwey, Ahmed
    NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (08) : 771 - 776
  • [46] SERUM LEVEL OF PROTEIN BOUND RADIOACTIVE IODINE (I-131) IN THE DIAGNOSIS OF HYPERTHYROIDISM
    FREEDBERG, AS
    URELES, A
    HERTZ, S
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1949, 70 (04): : 679 - 682
  • [47] Patient release criteria following radioactive iodine-131 treatment in the light of international practice: where does South Africa fit in?
    Mongane, Modisenyane S.
    Rae, William I. D.
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (10) : 805 - 809
  • [48] Is radioactive iodine-131 treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?
    de Souza, Marcelo Cruzick
    Momesso, Denise P.
    Vaisman, Fernanda
    Neto, Leonardo Vieira
    Gomes Martins, Rosangela Aparecida
    Corbo, Rossana
    Vaisman, Mario
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2016, 60 (01): : 9 - 15
  • [49] Successful Ablation of Lingual Thyroid Imaged with SPECT/CT and Treated with Radioactive Iodine-131 Avoiding Surgery and its Associated Risks
    Gandhi, Arpit
    Wong, Ka Kit
    Gross, Milton
    Avram, Anca
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [50] Recurrence-free survival and prognostic factors after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma
    Iizuka, Y.
    Katagiri, T.
    Ogura, K.
    Inoue, M.
    Nakamura, K.
    Mizowaki, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S364 - S364